The Ninth Circuit U.S. Court of Appeals on Monday ruled that pharmaceutical sales representatives are exempt from federal overtime laws, creating what some see as an appellate court split that could find its way to the U.S. Supreme Court.
The three-judge panel upheld a lower court ruling rejecting a proposed class action against GlaxoSmithKline for not paying sales representatives overtime. The ruling deviated from an earlier one in July by the Second Circuit and by a stance asserted by the Department of Labor in amicus curiae briefs in both cases.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
